Pfizer Post-market Report vs. National Loan Status

Post #777

In the 5.3.6 post-marketing report on the safety of Pfizer/BioNTech mRNA shots, they broke down how many adverse event reports (AERs) occurred in 7 top nations by 28 Feb 2021. When correlating those raw counts to the number of Pfizer shots administered, you can get an AER reporting rate per million doses.

When that AER rate per million doses is graphed against the share of all loans in serious (90+ days) delinquency during the year of 2019, then you get this:

With only 6 nations in the data set (Pfizer uptake in UK not found yet), there was still moderate correlation. Portugal’s rate was the worst, at over 1,000 AERs per million doses (and 6.2% of the value of all loans being over 90 days past due). The AER reporting rate in Portugal was almost 5 times higher than the lowest value (in Spain).

Counterintuitive socio-economic findings during COVID have been reported, and one of the better reviews on the matter is found here. Because the answers are not all in, it pays off to continue to explore connections of viral virulence with socio-economic factors.

An example of an at-least-apparent link between COVID and Socio-economic Level:

For the week of 13 Nov 2020 — just prior to the time when COVID shots were about to roll out — living in a wealthy nation meant being more likely to die from COVID, while being in a poor nation meant lower risk.

Reference

[uptake of Pfizer mRNA shots by 26 Feb 2021] — OurWorldInData. https://ourworldindata.org/covid-vaccinations

[Pfizer report on safety out to 28 Feb 2021] — https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf

[nonperforming (90+ days past due) loan share of 2019] — World Bank. https://databank.worldbank.org/source/world-development-indicators/Series/FB.AST.NPER.ZS